recursion logo on sign outside of brick building
Posted in General

H|T: The Healthtech Times – Recursion secures $50M from Nvidia following Canadian drug-discovery acquisitions

Plus: Ditch Labs wants to treat nicotine addiction with tech. The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around…

Continue Reading H|T: The Healthtech Times – Recursion secures $50M from Nvidia following Canadian drug-discovery acquisitions
A|I: The AI Times – FTC investigates OpenAI as Elon Musk launches competitor
Posted in General

A|I: The AI Times – FTC investigates OpenAI as Elon Musk launches competitor

Plus: Shopify teases AI assistant for entrepreneurs, Sidekick. The AI Times is a weekly newsletter covering the biggest AI, machine learning, big data, and…

Continue Reading A|I: The AI Times – FTC investigates OpenAI as Elon Musk launches competitor
BDC Logo
Posted in General

Canada attracts 30,000 tech workers, BDC wants Thrive co-investment partners

Plus: Shopify is building entrepreneurs an AI Sidekick. Welcome to BetaKit’s startup stories of the week! Here, you will find the week’s most important…

Continue Reading Canada attracts 30,000 tech workers, BDC wants Thrive co-investment partners
recursion logo on sign outside of brick building
Posted in General

After buying Cyclica and Valence, Recursion secures $50 million USD from Nvidia for drug discovery

Recursion, a US-based biotech firm, opened a new Canadian headquarters in Toronto last month. Computing giant Nvidia has invested $50 million USD in Recursion…

Continue Reading After buying Cyclica and Valence, Recursion secures $50 million USD from Nvidia for drug discovery
doctor, health
Posted in General

H|T: The Healthtech Times – Recursion acquires two Canadian AI drug-discovery companies

Plus: FDA commissioner: “hard to catch up” on regulating digital health. The Healthtech Times is a weekly newsletter covering healthtech news from Canada and…

Continue Reading H|T: The Healthtech Times – Recursion acquires two Canadian AI drug-discovery companies
A|I: The AI Times – At I/O, Google makes up for lost time
Posted in General

A|I: The AI Times – At I/O, Google makes up for lost time

Plus: Bessemer and SoftBank bet big on AI. The AI Times is a weekly newsletter covering the biggest AI, machine learning, big data, and…

Continue Reading A|I: The AI Times – At I/O, Google makes up for lost time
Toronto briefedin
Posted in General

Canadian startup news of the week (5/14/23)

Welcome to BetaKit’s startup stories of the week! Here, you will find the week’s most important news, features, and editorials published on BetaKit. If…

Continue Reading Canadian startup news of the week (5/14/23)
American biotech Recursion acquires two Canadian AI drug-discovery companies, Cyclica and Valence
Posted in General

American biotech Recursion acquires two Canadian AI drug-discovery companies, Cyclica and Valence

“Policymakers should look to understand why so many promising tech companies choose to sell themselves.” An American biotech company is acquiring Cyclica and Valence…

Continue Reading American biotech Recursion acquires two Canadian AI drug-discovery companies, Cyclica and Valence